Apogee Therapeutics, Inc. (APGE)
134.97
+0.01
(+0.01%)
USD |
NASDAQ |
Aug 28, 16:00
134.96
0.00 (0.00%)
After-Hours: 20:00
Apogee Therapeutics Free Cash Flow : -243.96M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -243.96M |
| March 31, 2026 | -235.37M |
| December 31, 2025 | -232.60M |
| September 30, 2025 | -237.56M |
| June 30, 2025 | -226.58M |
| March 31, 2025 | -193.13M |
| December 31, 2024 | -172.33M |
| September 30, 2024 | -134.53M |
| Date | Value |
|---|---|
| June 30, 2024 | -111.14M |
| March 31, 2024 | -96.36M |
| December 31, 2023 | -74.93M |
| September 30, 2023 | -54.20M |
| June 30, 2023 | -41.55M |
| March 31, 2023 | -26.98M |
| December 31, 2022 | -16.43M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cogent Biosciences, Inc. | -309.24M |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| Intellia Therapeutics, Inc. | -348.69M |
| Revolution Medicines, Inc. | -1.232B |
| Erasca, Inc. | -98.08M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -71.38M |
| Cash from Investing (Quarterly) | -381.86M |
| Cash from Financing (Quarterly) | 107.02M |
| Free Cash Flow Per Share (Quarterly) | -0.9461 |
| Free Cash Flow to Equity (Quarterly) | -169.40M |
| Free Cash Flow to Firm (Quarterly) | -69.80M |
| Free Cash Flow Yield | -2.66% |